Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
61-75 of 3352 results
Vernalis receives $2.5m final payment from Genentech
05 March 2013 | By PBR Staff Writer
Vernalis has obtained a final payment of $2.5m from its drug discovery collaboration with Genentech, a member of the Roche Group.
Drug Research > Drug Discovery & Development > News
Spring Bank Pharma raises $10.5m in Series A Financing
04 March 2013 | By PBR Staff Writer
US-based biopharmaceutical company Spring Bank Pharmaceuticals has closed a $10.5m Series A financing round from Brock Securities with Gilford Securities as a participator.
Drug Research > Drug Discovery & Development > News
Swallow Solutions completes Series A Financing
04 March 2013 | By PBR Staff Writer
US-based life sciences company Swallow Solutions has raised $1.046m in Series A financing, led by Venture Management, with participation from NEW Capital Fund, Wisconsin Investment Partners, and individual investors.
Drug Research > Drug Discovery & Development > News
TriLink to develop NGS RNA sample preparation approach
04 March 2013 | By PBR Staff Writer
The National Institutes of Health (NIH) has awarded a Phase I small business innovation research (SBIR) grant to TriLink BioTechnologies to use its expertise in nucleic acid chemistry and develop an approach to RNA sample preparation for Next Generation Sequencing (NGS).
Drug Research > Drug Discovery & Development > News
Kala Pharmaceuticals raises $11.5m in Series A financing round
04 March 2013 | By PBR Staff Writer
Kala Pharmaceuticals, a developer of products that effectively penetrate the mucosal barrier to treat various debilitating diseases, has received $11.5m in Series A equity financing round, led by new and existing investors.
Drug Research > Drug Discovery & Development > News
Mylan Pharmaceuticals launches Fenofibrate Capsules
26 February 2013 | By PBR Staff Writer
Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP, 43 mg and 130 mg.
Drug Research > Drug Discovery & Development > News
Ablynx inks deal with Spirogen to evaluate novel anti-cancer drug conjugate
25 February 2013 | By PBR Staff Writer
Ablynx has signed a collaborative agreement with Spirogen to evaluate the potential of a novel anti-cancer drug conjugate.
Drug Research > Drug Discovery & Development > News
UCB, ConfometRx sign drug discovery research deal
25 February 2013 | By PBR Staff Writer
Belgium-based biopharmaceutical company UCB has signed a research deal with ConfometRx for the discovery of new drugs.
Drug Research > Drug Discovery & Development > News
Colorado University, Orphan Technologies to develop new treatment for homocystinuria
22 February 2013 | By PBR Staff Writer
The University of Colorado (CU) has signed an exclusive, worldwide licensing and collaboration agreements with Orphan Technologies to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria.
Drug Research > Drug Discovery & Development > News
Lupin to commence shipment of Suprax oral suspension
22 February 2013 | By PBR Staff Writer
Lupin Pharmaceuticals has obtained FDA approval for Suprax (Cefixime) for oral suspension, 500 mg/5mL and anticipates initiating product shipment shortly.
Drug Research > Drug Discovery & Development > News
U3 Pharma, AbCheck in antibody discovery research collaboration
18 February 2013 | By PBR Staff Writer
U3 Pharma, an antibody targeted cancer drug development affiliate of Daiichi Sankyo, has signed a research collaboration deal with AbCheck.
Drug Research > Drug Discovery & Development > News
MorphoSys, Heptares to jointly develop antibody therapeutics against GPCRs
18 February 2013
MorphoSys and Heptares Therapeutics have signed a research deal to develop antibody therapeutics against G protein-coupled receptors (GPCRs).
Drug Research > Drug Discovery & Development > News
Novo Nordisk to launch new diabetes therapy in Japan
15 February 2013 | By PBR Staff Writer
Novo Nordisk has received an approval of the price from Japan's Central Social Insurance Medical Council (Chuikyo), the advisory committee to the Minister of Health, Labour and Welfare, and is set to launch Tresiba (insulin degludec) in Japan.
Drug Research > Drug Discovery & Development > News
Aurobindo Pharma wins FDA marketing approval for diabetes drugs
15 February 2013 | By PBR Staff Writer
The USFDA has issued final approval to manufacture and market Aurobindo Pharma's diabetes drugs, Pioglitazone tablets and Pioglitazone Hydrochloride + Metformin Hydrochloride tablets.
Drug Research > Drug Discovery & Development > News
Santarus launches new ulcerative colitis therapy
15 February 2013 | By PBR Staff Writer
Specialty biopharmaceutical company Santarus has announced the commercial launch of ulcerative colitis therapy, Uceris (budesonide) extended release tablets.
Drug Research > Drug Discovery & Development > News
61-75 of 3352 results